Loading…

Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer

The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied polymer science 2001-11, Vol.82 (8), p.1844-1849
Main Authors: Meirim, M. G., Neuse, E. W., N'Da, D. D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23
cites cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23
container_end_page 1849
container_issue 8
container_start_page 1844
container_title Journal of applied polymer science
container_volume 82
creator Meirim, M. G.
Neuse, E. W.
N'Da, D. D.
description The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley & Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001
doi_str_mv 10.1002/app.2027
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_21470103</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>582407</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhq2qlbqlSPwEX1r14mVsJ3FyhFVLEbSAWsTRcpwJa3A-sBPB3vrTMdpV6aWnGWme99HoJeSAw5IDiEMzjksBQr0hCw6VYlkhyrdkkU6clVWVvycfYrwD4DyHYkH-rEwIDgOrh7lvaIfTepgCPpkJl_R0SW_SElgc_Fx7pOPgNyaOJkymcw2yf3Fqh_5uvk1bpI9uWlOMKUq96-8jdT2d1tt8l3xNmG9p8lgMH8m71viI-7u5R66_ff29-s7OL05OV0fnzMpCKFbLvBWVgczwBhF53uaASmVFXjSlraoajCpkCU1m67yuLVphbdmWHFFmbS3kHvm89Y5heJjTb7pz0aL3psdhjlrwTAEHmcAvW9CGIcaArR6D60zYaA76pWKdKtYvFSf0085pojW-Daa3Lr7yGSgQGU8c23KPzuPmvz59dHm58-54lyp8-subcK8LJVWub36e6Cv5A34dF2dayWceJZx8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21470103</pqid></control><display><type>article</type><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><source>Wiley</source><creator>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</creator><creatorcontrib>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</creatorcontrib><description>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley &amp; Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</description><identifier>ISSN: 0021-8995</identifier><identifier>EISSN: 1097-4628</identifier><identifier>DOI: 10.1002/app.2027</identifier><identifier>CODEN: JAPNAB</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Agents ; antifolate agent ; Applied sciences ; Aromatic compounds ; bioavailability ; Biological and medical sciences ; Diseases ; Esters ; Exact sciences and technology ; General pharmacology ; macromolecular carrier ; Macromolecules ; Medical sciences ; methotrexate ; Natural polymers ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Physicochemistry of polymers ; Polyamides ; polymer-drug conjugation ; Proteins ; Purification ; Reaction kinetics ; Solubility ; Water</subject><ispartof>Journal of applied polymer science, 2001-11, Vol.82 (8), p.1844-1849</ispartof><rights>Copyright © 2001 John Wiley &amp; Sons, Inc.</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</citedby><cites>FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14070241$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Meirim, M. G.</creatorcontrib><creatorcontrib>Neuse, E. W.</creatorcontrib><creatorcontrib>N'Da, D. D.</creatorcontrib><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><title>Journal of applied polymer science</title><addtitle>J. Appl. Polym. Sci</addtitle><description>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley &amp; Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</description><subject>Agents</subject><subject>antifolate agent</subject><subject>Applied sciences</subject><subject>Aromatic compounds</subject><subject>bioavailability</subject><subject>Biological and medical sciences</subject><subject>Diseases</subject><subject>Esters</subject><subject>Exact sciences and technology</subject><subject>General pharmacology</subject><subject>macromolecular carrier</subject><subject>Macromolecules</subject><subject>Medical sciences</subject><subject>methotrexate</subject><subject>Natural polymers</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemistry of polymers</subject><subject>Polyamides</subject><subject>polymer-drug conjugation</subject><subject>Proteins</subject><subject>Purification</subject><subject>Reaction kinetics</subject><subject>Solubility</subject><subject>Water</subject><issn>0021-8995</issn><issn>1097-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kE1P3DAQhq2qlbqlSPwEX1r14mVsJ3FyhFVLEbSAWsTRcpwJa3A-sBPB3vrTMdpV6aWnGWme99HoJeSAw5IDiEMzjksBQr0hCw6VYlkhyrdkkU6clVWVvycfYrwD4DyHYkH-rEwIDgOrh7lvaIfTepgCPpkJl_R0SW_SElgc_Fx7pOPgNyaOJkymcw2yf3Fqh_5uvk1bpI9uWlOMKUq96-8jdT2d1tt8l3xNmG9p8lgMH8m71viI-7u5R66_ff29-s7OL05OV0fnzMpCKFbLvBWVgczwBhF53uaASmVFXjSlraoajCpkCU1m67yuLVphbdmWHFFmbS3kHvm89Y5heJjTb7pz0aL3psdhjlrwTAEHmcAvW9CGIcaArR6D60zYaA76pWKdKtYvFSf0085pojW-Daa3Lr7yGSgQGU8c23KPzuPmvz59dHm58-54lyp8-subcK8LJVWub36e6Cv5A34dF2dayWceJZx8</recordid><startdate>20011121</startdate><enddate>20011121</enddate><creator>Meirim, M. G.</creator><creator>Neuse, E. W.</creator><creator>N'Da, D. D.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011121</creationdate><title>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</title><author>Meirim, M. G. ; Neuse, E. W. ; N'Da, D. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Agents</topic><topic>antifolate agent</topic><topic>Applied sciences</topic><topic>Aromatic compounds</topic><topic>bioavailability</topic><topic>Biological and medical sciences</topic><topic>Diseases</topic><topic>Esters</topic><topic>Exact sciences and technology</topic><topic>General pharmacology</topic><topic>macromolecular carrier</topic><topic>Macromolecules</topic><topic>Medical sciences</topic><topic>methotrexate</topic><topic>Natural polymers</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemistry of polymers</topic><topic>Polyamides</topic><topic>polymer-drug conjugation</topic><topic>Proteins</topic><topic>Purification</topic><topic>Reaction kinetics</topic><topic>Solubility</topic><topic>Water</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meirim, M. G.</creatorcontrib><creatorcontrib>Neuse, E. W.</creatorcontrib><creatorcontrib>N'Da, D. D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Journal of applied polymer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meirim, M. G.</au><au>Neuse, E. W.</au><au>N'Da, D. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer</atitle><jtitle>Journal of applied polymer science</jtitle><addtitle>J. Appl. Polym. Sci</addtitle><date>2001-11-21</date><risdate>2001</risdate><volume>82</volume><issue>8</issue><spage>1844</spage><epage>1849</epage><pages>1844-1849</pages><issn>0021-8995</issn><eissn>1097-4628</eissn><coden>JAPNAB</coden><abstract>The antifolate‐type anticancer drug methotrexate (MTX) has for many years, in numerous laboratories, been a “workhorse” drug for conjugation with natural and synthetic macromolecular carriers for the purpose of enhancing bioavailability and lowering toxic side effects. In the project here described the polymer–drug conjugation strategy is utilized for the preparation of water‐soluble polyaspartamide–methotrexate conjugates in which the drug is carrier‐anchored through short spacers containing ester groups as biofissionable links. To this end, polyaspartamide carriers 1, poly‐α,β‐D,L‐N‐(2‐hydroxyethyl)aspartamide, and 2, poly‐α,β‐D,L‐N‐[2‐(2‐hydroxyethoxy)ethyl]aspartamide, are treated with MTX in DMF solution in the presence of a carbodiimide coupling agent and 4‐(dimethylamino)pyridine catalyst. The molar MTX/OH feed ratios, 0.28 and lower, are chosen in these coupling reactions so as to provide conjugates featuring drug‐loading levels in the approximate range of 3–16 mol % MTX, roughly corresponding to 6–28% by mass. The water‐soluble product polymers are purified by aqueous dialysis, collected in the solid state by freeze‐drying, and structurally characterized by 1H–NMR spectroscopy. © 2001 John Wiley &amp; Sons, Inc. J Appl Polym Sci 82: 1844–1849, 2001</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1002/app.2027</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-8995
ispartof Journal of applied polymer science, 2001-11, Vol.82 (8), p.1844-1849
issn 0021-8995
1097-4628
language eng
recordid cdi_proquest_miscellaneous_21470103
source Wiley
subjects Agents
antifolate agent
Applied sciences
Aromatic compounds
bioavailability
Biological and medical sciences
Diseases
Esters
Exact sciences and technology
General pharmacology
macromolecular carrier
Macromolecules
Medical sciences
methotrexate
Natural polymers
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Physicochemistry of polymers
Polyamides
polymer-drug conjugation
Proteins
Purification
Reaction kinetics
Solubility
Water
title Carrier-bound methotrexate. I. Water-soluble polyaspartamide-methotrexate conjugates with ester links in the polymer-drug spacer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A07%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carrier-bound%20methotrexate.%20I.%20Water-soluble%20polyaspartamide-methotrexate%20conjugates%20with%20ester%20links%20in%20the%20polymer-drug%20spacer&rft.jtitle=Journal%20of%20applied%20polymer%20science&rft.au=Meirim,%20M.%20G.&rft.date=2001-11-21&rft.volume=82&rft.issue=8&rft.spage=1844&rft.epage=1849&rft.pages=1844-1849&rft.issn=0021-8995&rft.eissn=1097-4628&rft.coden=JAPNAB&rft_id=info:doi/10.1002/app.2027&rft_dat=%3Cproquest_cross%3E582407%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3627-b35f29a04a1deee15f50e774656d8c99b0a76380d4cb5bbcec2cc8f81ee34fb23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=21470103&rft_id=info:pmid/&rfr_iscdi=true